findmyKOL
Clinical trialNCT00350298CompletedPhase 2Interventional

Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease

SponsorMassBiologicsEnrollment200Clostridium Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Calgary Foothills Medical Center

    Calgary, Alberta, Canada

  • Vancouver Island Health Research Centre

    Victoria, British Columbia, Canada

  • Health Sciences Centre, University of Manitoba

    Winnepeg, Manitoba, Canada

  • Kingston General Hospital

    Kingston, Ontario, Canada

  • Windsor Regional Hospital

    Windsor, Ontario, Canada

  • Centre de Sante Et Services Sociaux de Chicoutimi

    Chicoutimi, Quebec, Canada

  • Centre Hospitalier Regional de Trois-Rivieres

    Trois-Rivières, Quebec, Canada

United States
  • Lac/usc Medical Center

    Los Angeles, California, United States

  • Ucla Cure Digestive Diseases Center

    Los Angeles, California, United States

  • Kaiser Permanente Vaccine Study Center

    Oakland, California, United States

  • Christiana Care Health Systems

    Newark, Delaware, United States

  • Dr. Kiran C. Patel Research Institute

    Tampa, Florida, United States

  • Idaho Falls Infectious Diseases, Pllc

    Idaho Falls, Idaho, United States

  • Central Indiana Gastroenterology Group

    Anderson, Indiana, United States

  • Chest, Infectious Diseases and Critical Care Assoc., Pc

    Des Moines, Iowa, United States

  • University of Kentucky Medical Center

    Lexington, Kentucky, United States

  • Henry Ford Health System

    West Bloomfield, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Saint Luke'S Hospital of Kansas City

    Kansas City, Missouri, United States

  • Saint James Healthcare

    Butte, Montana, United States

  • Jersey Shore University Medical Center

    Neptune City, New Jersey, United States

  • Mount Sinai Hospital

    New York, New York, United States

  • All-Trials Clinical Research, Llc

    Winston-Salem, North Carolina, United States

  • Summa Health System

    Akron, Ohio, United States

  • Remington-Davis Clinical Research

    Columbus, Ohio, United States

  • Rapid City Regional Hospital

    Rapid City, South Dakota, United States

  • St. Lukes Episcopal Hospital

    Houston, Texas, United States

  • Scott and White Memorial Hospital

    Temple, Texas, United States

  • Multicare Health System Research Services

    Tacoma, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Jul 2006
Primary completion
25 Jun 2008
Completion
25 Jun 2008
Last update posted
9 Feb 2021
Registered enrollment
200
Registry id
NCT00350298

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.